Abstract
The synthesis of ε-aminocaproic acid esters is described. Two representative members from a group of five of the 1-alkyl homologues synthetized as flexible analogues of 1-alkylazacycloheptanone derivatives were evaluated in vitro for their effectiveness on the transport of theophylline through the excised human cadaver skin in comparison with Azone. The 1-octyl- and 1-dodecyl-ε-aminocaproic acid esters (OCEAC and DDEAC) show excellent penetration enhancement. Donor samples contained 2.5% theophylline and 1% enhancers tested in three different vehicles. Fluxes of theophylline were increased with OCEAC about 19 times from olive oil, 45 times from water, and about 38 times from water–propylene glycol (3:2) vehicle toward controls (with DDEAC about 17, 39, and 35 times, respectively) and they were markedly higher than Azone under the given conditions. Acute LD50's (i.p. in mice) of OCEAC (DDEAC) were 245 mg/kg (352 mg/kg), with a slightly lower toxicity than Azone. OCEAC and DDEAC did not exhibit acute dermal irritation in vivo on rabbits at a 5% concentration in white petrolatum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
B. W. Barry. Dermatological Formulations. Percutaneous Absorption, Marcel Dekker, New York, 1983.
H. E. Boddé, J. Verhoeven, and L. M. J. van Driel. The skin compliance of transdermal drug delivery systems. CRC Crit. Rev. Ther. Drug Carrier Syst. 6:87–115 (1989).
M. Katz and B. J. Poulsen. In B. B. Brodie and J. Gillette (eds.), Handbook of Experimental Pharmacology, Vol. 28, Pt. 1, Springer-Verlag, New York, 1971, p. 103.
J. Hadgraft. Penetration enhancers in percutaneous absorption. Pharm. Int. 5:252–254 (1984).
W. A. Ritschel and O. L. Sprockel. Sorption promoters for topically applied substances. Drugs Today 24:613–628 (1988).
K. A. Walters. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery, Marcel Dekker, New York, 1989, pp. 197–233.
W. R. Pfister and D. S. T. Hsieh. Permeation enhancers compatible with transdermal drug delivery systems. I. Selection and formulation considerations. Pharm. Technol. Int. 3:32–36 (1991).
B. W. Barry. Mode of action of penetration enhancers in human skin. J. Control. Release 6:85–97 (1987).
B. W. Barry. Action of skin penetration enhancers—The lipid protein partitioning theory. Int. J. Cosmet. Sci. 10:281–293 (1988).
O. Wong, J. Huntington, T. Nishihata, and J. H. Rytting. New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers. Pharm. Res. 6:286–295 (1989).
V. J. Rhaadhyaksha and M. Vieo. Vehicle composition containing 1-dodecylazacycloheptan-2-ones. U.S. Patent 3.989.815 (1976).
H. Okamoto, M. Hashida, and H. Sezaki. Structure-activity relationship of 1-alkyl-or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. J. Pharm. Sci. 77:418–424 (1988).
J. A. Fix. Novel lysine esters used as absorption enhancing agents. Eur. Pat. Appl. 85400771.3 (1985).
P. Doležal, A. Hrabálek, P. Měřička, V. Klimešová, J. Klimeš, J. Sochor, and V. Semecký. Urychlovač transdermální penetrance. CS Pat. Appl. PV 4278-89 (1989).
J. H. Draize, G. Woodard, and H. O. Calvery. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82:377–390 (1944).
T. J. Franz. Percutaneous absorption. On relevance of in vitro data. J. Invest. Dermatol. 64:190–195 (1975).
A. Hrabálek, P. Doležal, V. Klimešová, and B. Grymová. Způsob výroby esterů ε-aminokapronové kyseliny. CS Pat. Appl. PV 2969-89 (1989).
Production of amino acid esters. Br. Patent 934,965 (1963). Chem. Abstr. 61:P9405f (1964).
V. E. Limanov, I. R. Svitova, T. B. Kruchenok, I. M. Tsvirova, and L. A. Yaroslavskaya. Synthesis and bactericidal activity of hydrochlorides of amino acid esters. Khim.-Farm. Zh. 18:1214–1217 (1984).
R. Ibuki. Ph.D. thesis, University of Kansas, Lawrence, 1985. (Ref. 10.)
Registry of Toxic Effects of Chemical Substances, 1976 ed., NIOSH, U.S. DHEW, Rockville, MD, 1976. In J. Marhold (ed.), Přehled průmyslové toxikologie, Organické látky, Vol. 1, Avicenum, Prague, 1986, p. 738.
Registry of Toxic Effects of Chemical Substances, 1977 ed., NIOSH, U.S. DHEW, Cincinnati, OH, 1977. In J. Marhold, (ed.), Přehled průmyslové toxikologie, Organické látky, Vol. 1, Avicenum, Prague, 1986, p. 200.
M. Goodman and B. W. Barry. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:323–327 (1988).
A. C. Williams and B. W. Barry. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8:17–24 (1991).
E. R. Cooper and B. Bernet. In D. Skerrow and C. J. Skerrow (eds.), Methods in Skin Research, J. Wiley & Sons, Chichester, 1985, pp. 407–432.
R. B. Stoughton and W. O. McClure. Azone: A new non-toxic enhancer of cutaneous penetration. Drug Dev. Ind. Pharm. 9:725–744 (1983).
E. R. Cooper. Improved penetrating topical pharmaceutical composition containing 1-dodecyl-azacycloheptan-2-one. Eur. Pat. Appl. 84200822.9 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doležal, P., Hrabálek, A. & Semecký, V. ε-Aminocaproic Acid Esters as Transdermal Penetration Enhancing Agents. Pharm Res 10, 1015–1019 (1993). https://doi.org/10.1023/A:1018914806761
Issue Date:
DOI: https://doi.org/10.1023/A:1018914806761